Morphic Holding, Inc. (MORF) Stock Analysis
DELISTED 2024
What happened to Morphic Holding, Inc. (MORF) stock?
Morphic Holding, Inc. (MORF) no longer trades on public markets. It was delisted in August 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- August 2024
- Last recorded price (historical):
- $56.99 (last quote on record before the August 2024 delisting; historical, not a current quote)
Market cap $2.86B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Morphic Holding, Inc. (MORF). Morphic Holding, Inc. is a biopharmaceutical company focused on developing oral small-molecule integrin therapeutics. Their lead product candidate, MORF-057, targets inflammatory bowel disease and is currently in Phase 1 clinical trials.
Last analyzed: May 8, 2026Morphic Holding, Inc. (MORF) Healthcare & Pipeline Overview
More about this archive record
Can I still buy MORF shares?
No. MORF stopped trading on public markets in August 2024, so the shares are not available through a broker. Anything you see quoted for MORF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before MORF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Morphic Holding, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.